Skip To Main Content
Jian-Ying Wang on Muck Rack

Jian-Ying Wang

As seen in: Nature, Wiley Online Library, Gastrointestinal Endoscopy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jian-Ying

Contact Jian-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Hee Kyoung Chung, Min Kwon, Tingxi Yu, Hongxia Chen, Amy Vander Stoep, Haonan Zhao, Lan Xiao, Jian-Ying Wang, Bridgette Warner
| Gastrointestinal Endoscopy Verified
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Open in Who Shared View Duplicates (441) Issue with article?

Tu1289 SMALL NONCODING VAULT RNA1-1 REGULATES STEM CELL MAINTENANCE IN THE INTESTINAL EPITHELIUM BY ALTERING PANETH CELL FUNCTION

|
By Amy Vander Stoep, Douglas Turner, Tingxi Yu, Hee Kyoung Chung, Min Kwon, Hongxia Chen, Haonan Zhao, Myriam Gorospe, Lan Xiao, Jian-Ying Wang
| Gastrointestinal Endoscopy Verified
Also available on ScienceDirect
Open in Who Shared Issue with article?

Prediabetes as an indication for GLP-1 therapy. Clarifying evidence thresholds and clinical guardrails - International Journal of Obesity

|
By Jian-Ying Wang
| Nature Verified
To the Editor: The Perspective on prediabetes as a potential indication for GLP-1 therapy raises an important clinical and policy question [1]. Any new indication should rest on outcomes that matter for patients and payers and on a clear definition of who benefits most.
Open in Who Shared Issue with article?
See all 6 articles